Wang Lai
SEC CIK 1852291 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd. | Pres, Gbl Head of R, D | 0 | — | $9.32M | 32 | 2021-09-28 | 2026-06-23 |
Most active insiders at ONC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OYLER JOHN | CEO, Dir | — | $327.88M |
| 2 | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | — | $13.37M |
| 3 | Wu Xiaobin | Pres, COO | — | $8.75M |
| 4 | Lee Chan Henry | SVP, GC | — | $7.95M |
| 5 | Wang Lai | Pres, Gbl Head of R, D | — | $1.17M |
| 6 | Sanders Corazon (Corsee) D. | Dir | — | $961.2K |
| 7 | Rosenberg Aaron | CFO | — | $524.4K |
| 8 | BAKER BROS. ADVISORS LP | Dir | — | $262.0K |
| 9 | Ball Titus B. | Principal Accounting Off | — | $127.3K |
| 10 | Dugan Margaret | Dir | — | $65.6K |
Transactions 32
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-25 17:14 | 2026-06-23 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $276.74 | -1,068 | 0 | -100% | -$295.6K | |
| 2026-06-18 17:19 | 2026-06-16 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $265.39 | -1,169 | 0 | -100% | -$310.2K | |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +118.6K | 1.71M | +7% | $0 |
| D | 2026-06-15 17:55 | 2026-06-11 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $261.00 | -756 | 0 | -100% | -$197.3K |
| M | 2026-06-10 17:25 | 2026-06-08 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | S - Sale | $269.38 | -1,367 | 0 | -100% | -$368.2K |
| M | 2026-03-10 | 2026-03-06 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +167.6K | 1.62M | +12% | $0 |
| 2026-01-05 | 2025-12-31 | ONC | BeOne Medicines Ltd. | Wang Lai | Pres, Gbl Head of R, D | A - Grant | $0.00 | +427.9K | 1.45M | +42% | $0 | |
| I | 2025-09-11 | 2025-09-09 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $350.06 | -5,000 | 0 | -100% | -$1.75M |
| MI | 2025-07-31 | 2025-07-29+ | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $302.65 | -4,300 | 259 | -94% | -$1.30M |
| I | 2025-07-22 | 2025-07-18 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $300.00 | -700 | 0 | -100% | -$210.0K |
| 2025-06-25 | 2025-06-23 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $260.00 | -1,028 | 0 | -100% | -$267.3K | |
| M | 2025-06-18 | 2025-06-16+ | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $262.11 | -1,647 | 0 | -100% | -$431.7K |
| D | 2025-06-12 | 2025-06-10 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +86.4K | 1.06M | +9% | $0 |
| M | 2025-06-10 | 2025-06-06 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $252.39 | -1,402 | 600 | -70% | -$353.9K |
| 2025-03-07 | 2025-03-05 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +69.3K | 990.2K | +8% | $0 | |
| MI | 2025-02-25 | 2025-02-21 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $257.23 | -5,000 | 2,619 | -66% | -$1.29M |
| I | 2024-10-01 | 2024-09-27 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $220.35 | -5,000 | 0 | -100% | -$1.10M |
| M | 2024-06-26 | 2024-06-24 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $159.80 | -1,064 | 0 | -100% | -$170.0K |
| M | 2024-06-20 | 2024-06-17+ | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $157.27 | -2,341 | 1,626 | -59% | -$368.2K |
| D | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +168.9K | 1.77M | +11% | $0 |
| M | 2023-06-27 | 2023-06-26 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $181.92 | -1,108 | 5 | -100% | -$201.6K |
| D | 2023-06-20 | 2023-06-15 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +133.6K | 1.61M | +9% | $0 |
| D | 2023-06-20 | 2023-06-20 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $192.42 | -1,325 | 0 | -100% | -$255.0K |
| M | 2023-06-09 | 2023-06-07 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $224.74 | -462 | 227 | -67% | -$103.8K |
| 2022-06-28 | 2022-06-27 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $177.32 | -458 | 0 | -100% | -$81.2K | |
| D | 2022-06-24 | 2022-06-22 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | $0.00 | +125.3K | 1.51M | +9% | $0 |
| M | 2022-06-22 | 2022-06-17+ | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $145.35 | -1,168 | 0 | -100% | -$169.8K |
| 2022-06-08 | 2022-06-06 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | S - Sale | $142.00 | -660 | 0 | -100% | -$93.7K | |
| DM | 2022-05-19 | 2022-05-17 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | M - OptEx | $3.26 | +1.23M | 1.41M | +707% | +$4.03M |
| I | 2021-12-17 | 2021-12-15 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | A - Grant | — | 0 | 0 | New | — |
| MI | 2021-12-17 | 2021-10-31 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | G - Gift | $0.00 | 0 | 58.2K | New | $0 |
| 2021-12-17 | 2021-09-28 | ONC | BeOne Medicines Ltd. | Wang Lai | Gbl Head of R, D | G - Gift | $0.00 | -58.2K | 174.6K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations